Prevention of chronic furunculosis with low-dose azithromycin

Journal of Dermatological Treatment

Volumn 18, Issue 2, 2007, Pages 105-108

  Aminzadeh, Arya ^a,b   Demircay, Zeynep ^a   Ocak, Kerem ^a   Soyletir, Guner ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Azithromycin; Chronic furunculosis; E test; Staphylococcus aureus; Suppressive treatment

Indexed keywords

AZITHROMYCIN; METICILLIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; FEMALE; FOLLOW UP; FURUNCULOSIS; GASTROINTESTINAL SYMPTOM; HUMAN; IN VITRO STUDY; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FURUNCULOSIS; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 34249073437     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630601165125     Document Type: Article

References (18)

1. Lee PK, Weinberg AN, Swartz MN, Johnson RA. Pyodermas: Staphylococcus aureus, Streptococcus, and other gram-positive bacteria. In: Freedberg IM, Eisen AZ, Wolff K, Austen FK, Goldsmith LA, Katz SI, et al., editors. Fitzpatrick's dermatology in general medicine. 5th ed, Vol. 2. New York: McGraw-Hill; 1999. p. 2182-91.
2. Hirschmann JV. Skin infections caused by Staphylococci, Streptococci, and the resident cutaneous flora. In: Arndt KA, Leboit PE, Robinson JK, editors. , Cutaneous medicine and surgery. 1st ed, Vol. 2. Philadelphia: Saunders Company; 1996. p. 919-30.
3. Tuazon CU. Skin and skin structure infections in the patient at risk: Carrier state of Staphylococcus aureus. Am J Med. 1984;5:166-71.
4. Alverez-Elcoro S, Enzler MJ. The macrolides: Erithromycin, clarithromycin, and azithromycin. Mayo Clin Proc. 1999;74:613-34.
5. Amaya-Tapia G, Aguirre-Avalos G, Andrade-Villanueva J, Peredo-Gonzalez G, Morfin-Otero R, Esparza-Ahumada S, et al. Once-daily azithromycin in the treatment of adult skin and skin-structure infections. J Antimicrob Chemother. 1993;31suppl E: 129-35.
6. Tulloch LG, Alder VG, Gillespie WA. Treatment of chronic furunculosis. Br Med J. 1960;2:354-6.
7. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med. 1991;114:101-6.
8. Wheat LJ, Kohler RB, White A. Prevention of infections of skin and skin structures. Am J Med. 1984;76:187-90.
9. Wheat LJ, Kohler RB, White A. Treatment of nasal carriers of coagulase-positive staphylococci. In: Maibach H, Aly R, editors. Skin microbiology: Relevance to clinical infection. New York: Springer-Verlag Inc.; 1981. p. 50-8.
10. Hoss MD, Feder HM. Addition of rifampin to conventional therapy for recurrent furunculosis. Arch Dermatol. 1995;131:647-8.
11. Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy. JAMA. 1988;260:2682-5.
12. Taylor WR, Richie TL, Fryauff DJ, Picarima H, Ohrt C, Tang D, et al. Malaria prophylaxis using azithromycin: A double blind, placebo controlled trial in Irian Jaya, Indonesia. Clin Infect Dis. 1999;28:74-81.
13. Havlir DV, Dube MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med. 1996;335:392-8.
14. Labro MT. Immunological effects of macrolides. Curr Opin Infect Dis. 1998;11:681-8.
15. Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombola L, Carnuccio R, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther. 2000;292:156-63.
16. Amsden GW. Pharmacological considerations in the emergence of resistance. Int J Antimicrob Agents. 1999;11:7-14.
17. Oncu S, Punar M, Eraksoy H. Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates. Chemotherapy., 2004;50:98-100.
18. Eday EA. Bacterial resistance in acne. Dermatology. 1998;196:59-66.